Effects of interferon-alpha (IFN-α) administration on leucocytes in healthy humans

Clinical and Experimental Immunology

Volumn 107, Issue 2, 1997, Pages 359-363

  Corssmit, E P M ^a   Heijligenberg, R ^a   Hack, C E ^a   Endert, E ^a   Sauerwein, H P ^a   Romijn, J A ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

cytokines; interferons; lactoferin; leucocytes; neopterin

Indexed keywords

CYTOKINE; INTERLEUKIN 1; NEOPTERIN; RECOMBINANT ALPHA2B INTERFERON; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; HUMAN; HUMAN EXPERIMENT; LEUKOCYTE COUNT; MALE; MONOCYTE; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031024608     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1997.269-ce1161.x     Document Type: Article

References (34)

1. Baron S, Tyring SK, Fleischmann R et al. The interferons. Mechanism of action an clinical applications. JAMA 1991; 266:1375-83.
2. Taylor JR, Grossberg SE, Recent progress in interferon research: molecular mechanisms of regulation, action, and virus circumvention. Virus Res 1990; 15:1-12.
3. Weil J, Epstein CJ, Epstein LB, A unique set of polypeptides is induced by γ interferon in addition to those induced in common with α and β interferons. Nature 1983; 301:437-9.
4. Havell EA, Hayes TG, Vilcek J. Synthesis of two distinct interferons by human fibroblast. Virology 1978:89:330-4.
5. Shirafuji N, Matsuda S, Ogura H et al. Granulocyte-colony stimulating factor stimulates human mature neutrophilic granulocytes to produce interferon-alpha. Blood 1990; 75:17-19.
6. Wing EJ, Magee DM, Whiteside TI, Kaplan SS, Shadduck RK, Recombinant human granulocyte/macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor alpha and Interferon in cancer patients. Blood 1989; 73:643-6.
7. Tzung SP, Mahl TC, Lance P, Anderson V, Cohen SA. Interferon-alpha prevents endotoxin-induced mortality in mice. Eur J Immunol 1992; 22:3097-101.
8. Tilg H, Mier JW. Vogel W et al. Induction of circulating IL-1 receptor antagonist by IFN treatment. J Immunol 1993; 150:4687-92.
9. Schindler R, Ghezzi P, Dinarello CA. IL-1 induces IL-1, IV. IFN-γ suppresses IL-1 but not lipopolysaccharide-induced transcription of IL-1. J Immunol 1990; 144:2216-22.
10. Aman MJ, Rudolf G, Goldsehmitt J et al. Type-I interferons are potent inhibitors of interleukin-8 production in hemato-poietic and bone marrow stroma cells. Blood 1993; 82:2371-8.
11. Abu-Khabar KS, Armstrong JA, Ho M. Type-I interferons (IFN-alpha and -beta) suppress cytotoxin (tumor necrosis factor-alpha and lymphotoxin) production by mitogen-stimulated human peripheral blood mononuclear cells. J Leukoc Biol 1992; 52:165-72.
12. 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. J Lab Clin Med 1992; 119:159-68.
13. Hack CE, Hart M, Strack-van Schijndel RJM et al. Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 1992; 60:2835-42.
14. Godfried MH, van der Poll T, Weverling GJ el al. Soluble receptors for tumour necrosis factor as predictors of progression to aids in asymptomatic human immunodeficiency virus type 1 infection. J Infect Dis 1994; 169:739-45,
15. Girardin E, Roux-Lombard P, Grau GE. Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. Immunology 1992; 76:20-23.
16. Corssmit EPM, Heyligenberg R, Enden E, Sauerwein HP, Romijn JA. Acute effects of interferon-a administration on thyroid hormone metabolism in healthy men. J Clin Endocrinol Metab 1995; 80:3140-4.
17. Greaves MW. Anti-inflammatory action of corticosteroids. Postgrad Med J 1976; 52:631-5.
18. Dustin ML, Rothlein R, Bhan AK, Dinarello AC, Springer TA. Induction by IL-1 and Interferon, distribution, biochemistry and function of a natural adherence molecule (ICAM I). J Immunol 1986; 137:245-54.
19. Pober JS, Gimbrone mA, Lapierre LA et al. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor alpha and immune interferon. J Immunol 1986; 137:1893-6.
20. Carlos TM, Schwartz BR, Kovach NL et al. Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood 1990; 76:965-70.
21. Ulich TR, del Castillo J, Guo KZ. In vivo hematologic effects of recombinant interleukin-6 on hematopoiesis and circulating numbers of RBC's and WBCs. Blood 1989; 73:108-10.
22. Janoff A. Elastase in tissue injury. Ann Rev Med 1985; 36:207-16.
23. Bennet RM, Kokocinski T. Lactoferrin turnover in man. Clin Sci 1979: 57:453-60.
24. Borish L, Rosenbaum R, Albury L, Clark S. Activation of neutrophils by recombinant interleukin 6. Cell Immunol 1989; 121:280-9.
25. Fitzpatrick MM, Shah V, Trompeter RS, Dillon MJ, Barratt TM, Interleukin-8 and polymorphonuclear leukocyte activation in hemolytic uremic syndrome of childhood. Kidney Int 1992; 42:951-6.
26. Troppmair J, Nachbaur K, Herold M el at. In-vitro and in-vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens and lipopolysaccharide (LPS). Clin Exp Immunol 1988; 74:392-7.
27. Rosztoczy I, Content J. The effects of various cytokines on interleukin-6 and interferon-α synthesis in human peripheral blood mononucleair cells. J Interferon Res 1990; 10:637-45.
28. Tilg H, Vogel W, Dinarello CA, Interferon-a induces circulating tumor necrosis factor receptor p55 in humans. Blood 1995; 85:433-5.
29. Ohashi K, Akazawa R, Kurimoto M, Effects of interferon-alpha on a reduced release of interleukin-8 from latently HIV-1-infected monocytic cell line U937 cells. J Interferon Res 1994; 14:129-32.
30. Grunfeld C, Kotler DP, Shigenaga JK et al. Circulating interteron-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 1991; 90:154-62.
31. Bernier J, Reuter A, Vrindts-Gevaert, Franchimont P. Radioimmunoassay of leucocyte (alpha) Interferon and its application to some clinical conditions. J Nucl Med 1984; 25:765-72.
32. Grau GE, Roux-Lombard P, Gysler C et al. Serum cytokine changes in systemic vasculitis. Immunol 1989; 68:196-8.
33. Poynard T, Bedossa P, Chevallier M et al. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group. N Engl J Med 1995; 332:1457-62.
34. Cortes JE, Talpaz M, Kantarjian H. Chronic myelogenous leukemia: a review. Am J Med 1996; 100:555-70.